Merit Medical Shares Gain 2.78 % on Friday Amid Positive Momentum
Merit Medical Systems, Inc. (MMSI) experienced a 2.78 % rise during the 24‑hour trading window that closed at 09:32 AM Central Europe on Friday, 23 October 2026. The stock traded at USD 93.94 on major exchanges, reflecting a steady upward trajectory since the close of the previous month, when the share price was up 7.89 %.
Trading Metrics
- Shares Outstanding: 59.7 million
- Market Capitalization: USD 5.5 billion
- Volume (last 24 hrs): USD 61.5 million
- 200‑Day Simple Moving Average: USD 76.76
- 52‑Week High: USD 94.75 (1 January 2026)
- 52‑Week Low: USD 59.74 (5 December 2026)
The current price sits well above the 200‑day average, suggesting a bullish short‑term trend while remaining comfortably above the 52‑week low.
Peer Performance Snapshot (Last 24 hrs)
| Stock | Ticker | % Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Allegro Microsystems | ALGM | +1.77 % | USD 31.69 | USD 6.4 bn | 459.52 |
| Lantheus | LNTH | –0.14 % | USD 100.1 | USD 6.6 bn | 24.25 |
| Mining | SSRM | –7.18 % | USD 29.2 | USD 6.5 bn | 10.38 |
| United Bankshares | UBSI | +2.71 % | USD 48.46 | USD 6.4 bn | 12.85 |
| Sprouts Farmers Market | SFM | +5.11 % | USD 68.86 | USD 6.4 bn | 12.55 |
United Bankshares’ quarterly filing highlighted a modest earnings decline versus the prior quarter, yet a year‑ago comparison showed improvement. Record net interest income and robust loan growth underpin the bank’s solid outlook, supported by disciplined cost control and a strong capital base.
Company Overview
Merit Medical Systems, Inc. is headquartered in South Jordan, Utah, and specialises in the design, manufacture, and marketing of medical devices for diagnostic and interventional cardiology and radiology. Core product categories include inflation devices, guide wires, thrombolytic catheters, fluid dispensing systems, angiography accessories, and related supplies. The company’s products are distributed worldwide, and its shares are listed on Nasdaq. Merit Medical conducted its initial public offering in August 1990 and has maintained a focus on innovation and quality in the cardiovascular and interventional imaging markets.
The recent price movement reflects continued investor confidence in Merit Medical’s product pipeline and its strategic positioning within the rapidly evolving field of interventional cardiology.
